Publication Name	World Journal of Gastrointestinal Oncology
Manuscript ID	64568
Country	China

Received	2021-02-20 08:50
Peer-Review Started	2021-02-20 08:54
To Make the First Decision
Return for Revision	2021-03-29 18:14
Revised	2021-04-06 00:50
Second Decision	2021-06-17 12:31
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2021-06-17 12:50
Articles in Press	2021-06-17 12:50
Publication Fee Transferred
Edit the Manuscript by Language Editor	2021-06-26 03:02
Typeset the Manuscript	2021-07-05 07:41
Publish the Manuscript Online	2021-07-10 10:08

ISSN	1948-5204 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Immunology
Manuscript Type	Minireviews
Article Title	Neoantigen vaccine: An emerging immunotherapy for hepatocellular carcinoma
Manuscript Source	Invited Manuscript
All Author List	Pu Chen, Qiong-Xuan Fang, Dong-Bo Chen and Hong-Song Chen
Funding Agency and Grant Number	Funding Agency Grant Number National Key Sci-Tech Special Project of China 2018ZX10302207
Corresponding Author	Hong-Song Chen, PhD, Senior Scientist, Peking University Hepatology Institute, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Disease, Peking University People’s Hospital, No. 11 Xizhimen South Street, Beijing 100044, China. chenhongsong@bjmu.edu.cn
Key Words	Hepatocellular carcinoma; Neoantigen; Hepatitis B virus; Screening and identification; Immunosuppression; Immunotherapy
Core Tip	In previous studies of tumor immunotherapy strategies targeting neoantigens, the unique events generating the neoantigens in each tumor have not been well studied. In this paper, we analyzed the generation events of hepatocellular carcinoma (HCC) neoantigens. We also provide some methods for screening and identifying HCC neoantigens and clinical strategies for exploiting HCC neoantigens.
Publish Date	2021-07-10 10:08
Citation	Chen P, Fang QX, Chen DB, Chen HS. Neoantigen vaccine: An emerging immunotherapy for hepatocellular carcinoma. World J Gastrointest Oncol 2021; 13(7): 673-683
URL	https://www.wjgnet.com/1948-5204/full/v13/i7/673.htm
DOI	https://dx.doi.org/10.4251/wjgo.v13.i7.673

Full Article (PDF)	WJGO-13-673.pdf
Full Article (Word)	WJGO-13-673.docx
Manuscript File	64568_Auto_Edited-ZMG_WangTQ.docx
Answering Reviewers	64568-Answering reviewers.pdf
Audio Core Tip	64568-Audio core tip.wav
Conflict-of-Interest Disclosure Form	64568-Conflict-of-interest statement.pdf
Copyright License Agreement	64568-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	64568-Grant application form(s).pdf
Non-Native Speakers of English Editing Certificate	64568-Language certificate.pdf
Peer-review Report	64568-Peer-review(s).pdf
Scientific Misconduct Check	64568-Bing-Wang JL-1.jpg
Scientific Misconduct Check	64568-Bing-Fan JR-2.png
Scientific Misconduct Check	64568-Scientific misconduct check.pdf
Scientific Editor Work List	64568-Scientific editor work list.pdf
CrossCheck Report	64568-CrossCheck report.pdf
CrossCheck Report	64568-CrossCheck.png